MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41585-026-01172-5

Медицинская библиотека · Nature reviews. Urology · 2026

Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer.

Fletcher Sean A, Pickersgill Nicholas A, Osorio Juan C, McHugh Deaglan J, Nagar Himanshu, Kole Thomas, Janopaul-Naylor James, Lacuna Kristine, Eastham James A, Touijer Karim A, Fainberg Jonathan S, Scher Howard I, Ehdaie Behfar, Dallos Matthew C, Gaffney Christopher D

СтатьяОбзорПеревод пока не подготовлен

Аннотация

High-risk localized prostate cancer is associated with substantial recurrence rates despite definitive treatment, and no neoadjuvant therapies are currently established. Investigation in this field has largely focused on systemic neoadjuvant androgen deprivation therapy, which is associated with burdensome adverse effects and long-term morbidity. Intraprostatic immunotherapy is an emerging strategy designed to overcome local immune suppression and induce systemic antitumour responses through direct modulation of the tumour microenvironment. Early-phase clinical experience with viral-vector-based gene therapies has shown this approach to be safe, technically feasible and capable of eliciting local and systemic immune activation. Clinical efficacy remains unproven, with results from early-phase studies indicating variable responses in levels of prostate-specific antigen and pathological tumour regression. Nevertheless, these studies establish a proof-of-concept for localized immunomodulation before surgery. Further progress will require standardized biological and clinical end points and rational integration with contemporary treatment modalities.

Для цитирования: Fletcher Sean A, Pickersgill Nicholas A, Osorio Juan C, McHugh Deaglan J, Nagar Himanshu, Kole Thomas, Janopaul-Naylor James, Lacuna Kristine, Eastham James A, Touijer Karim A, Fainberg Jonathan S, Scher Howard I, Ehdaie Behfar, Dallos Matthew C, Gaffney Christopher D. Neoadjuvant intraprostatic immunotherapy for high-risk localized prostate cancer.. Nature reviews. Urology. 2026. DOI: 10.1038/s41585-026-01172-5.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.